SCOPUS 정보 검색 플랫폼

Volumn 35, Issue 4, 2001, Pages 512-516

Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: A UK multicentre study

(12) Caronia, Simona a Bassendine, Margaret F b Barry, Ralf c Mills, Peter d Naoumov, Nikolai V e Fox, Ray d Lowes, John f Hollanders, David g Murray Lyon, Iain h Irving, William L g Goldin, Robert D a Foster, Graham R a

a ST MARY S HOSPITAL (United Kingdom)

b FREEMAN HOSPITAL (United Kingdom)

c BRISTOL ROYAL INFIRMARY (United Kingdom)

d GARTNAVEL GENERAL HOSPITAL (United Kingdom)

e UNIVERSITY COLLEGE HOSPITAL (United Kingdom)

f TORBAY HOSPITAL (United Kingdom)

g Torbay Hospital ^* (United Kingdom)

h CHELSEA AND WESTMINSTER HOSPITAL (United Kingdom)

Author keywords

Amantadine; Combination chemotherapy; Hepatitis C virus; Interferon ; Multicentre trial

Indexed keywords

AMANTADINE; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FATIGUE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM; WEIGHT REDUCTION;

ADULT; AGED; AMANTADINE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0034793649 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-8278(01)00140-4 Document Type: Article

Times cited : (30)

References (16)

1
- 0033060563
- Global surveillance and control of hepatitis C
- (1999) J Viral Hepat , vol.6 , pp. 35-47

2
- 0028998145
- Clinical outcomes after transfusion associated hepatitis C virus
- (1995) N Engl J Med , vol.332 , pp. 1463-1466
- Tong, M.¹ El-Farrah, N.² Reikes, A.³ Co, R.⁴

3
- 0029833829
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
- (1996) Hepatology , vol.24 , Issue.4 , pp. 778-789
- Poynard, T.¹ Leroy, V.² Cohard, M.³ Thevenot, T.⁴ Mathurin, P.⁵ Opolon, P.⁶

4
- 0032585237
- Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- International Hepatitis Interventional Therapy Group (IHIT)
- (1998) Lancet , vol.352 , Issue.9138 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶

5
- 0032547938
- Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- Hepatitis Interventional Therapy Group (see comments)
- (1998) N Engl J Med , vol.339 , Issue.21 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶

6
- 0033406371
- EASL International consensus conference on hepatitis C: Consensus statement
- (1999) J Hepatol , vol.31

7
- 0034619946
- Peginterferon alpha-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , Issue.23 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³ Heathcote, E.J.⁴ Lai, M.Y.⁵ Gane, E.⁶

8
- 0034619980
- Peginterferon alpha-2a in patients with chronic hepatitis C and cirrhosis
- (2000) N Engl J Med , vol.343 , Issue.23 , pp. 1673-1680
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, W.G.³ Dusheiko, G.M.⁴ Lee, S.S.⁵ Balart, L.⁶

9
- 0018929513
- Inhibition of Dengue virus replication by amantadine hydrochloride
- (1980) Antimicrob Agents Chemother , vol.18 , pp. 125-129
- Koff, W.¹ Elm, J.² Halstead, S.³

10
- 0032898676
- The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C
- (1999) Semin Liver Dis , vol.19 , Issue.SUPPL. 1 , pp. 95-102
- Younossi, Z.M.¹ Perrillo, R.P.²

11
- 0030822539
- Treatment of chronic hepatitis C with amantadine
- (1997) Dig Dis Sci , vol.42 , pp. 1681-1687
- Smith, J.¹

12
- 0033807659
- Randomized, double-blind, placebo-controlled trial of interferon alpha2a with and without amantadine as initial treatment for chronic hepatitis C
- (2000) Hepatology , vol.32 , Issue.4 PART 1 , pp. 835-841
- Zeuzem, S.¹ Teuber, G.² Naumann, U.³ Berg, T.⁴ Raedle, J.⁵ Hartmann, S.⁶

13
- 0002048078
- Long term response to amantadine + interferon is significantly higher than that to interferon alone in chronic hepatitis C
- (2000) Hepatology , Issue.SUPPL.
- Mangia, A.¹ Santora, R.² Villani, M.³ Soccio, T.⁴ Cela, O.⁵ Annes, M.⁶

14
- 0030852143
- Management of chronic hepatitis C: Clinical audit of biopsy based management algorithm
- (1997) Br Med J , vol.315 , Issue.7106 , pp. 453-458
- Foster, G.R.¹ Goldin, R.D.² Main, J.³ Murray-Lyon, I.⁴ Hargreaves, S.⁵ Thomas, H.C.⁶

15
- 0033652858
- HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin
- (2000) J Viral Hepat , vol.7 , Issue.6 , pp. 409-413
- Carlsson, T.¹ Lindahl, K.² Schvarcz, R.³ Wejstal, R.⁴ Uhnoo, I.⁵ Shev, S.⁶

16
- 0033839967
- Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C
- (2000) Hepatology , vol.32 , Issue.3 , pp. 630-634
- Brillanti, S.¹ Levantesi, F.² Masi, L.³ Foli, M.⁴ Bolondi, L.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.